Ono Posts Record High H1 Earnings for 6th Consecutive Year Driven by Opdivo

Ono President Gyo Sagara Ono Pharmaceutical’s revenue and profits for the first half of FY2023 both climbed to all-time highs, renewing such records in the April-September period for the sixth straight fiscal year, according to its earnings results released on...read more